Anacalypsis Therapeutics
Anacalypsis Therapeutics is a Healthcare & Life Sciences startup based in Greece, most recent round Pre-Seed, 1 tracked investor.
About Anacalypsis Therapeutics
Anacalypsis Therapeutics is a startup founded in 2020 based in Greece. Its most recent tracked round is Pre-Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Anacalypsis Therapeutics is a biotech startup focused on the discovery and development of precision gene- and pathway-based disease-modifying therapeutic strategies to treat neurodegenerative diseases such as Parkinson’s Disease. They develop biomarkers for early detection and innovative treatments aimed at modifying disease progression.
Explore Anacalypsis Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.